Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Chemical Research in Toxicology|September 20, 2019
Involvement of Pazopanib and Sunitinib Aldehyde Reactive Metabolites in Toxicity and Drug-Drug Interactions in Vitro and in Patient SamplesMarie-Noëlle Paludetto, Jean-Luc Stigliani, Anne Robert, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|March 3, 2025
A comparative study of gellan gum and xanthan gum versus commercial vehicles as pharmaceutical thickening agents in oral suspensionsPauline Claraz, Luc Fillaudeau, Chloé Jadoul, et al.
Therapeutic Drug Monitoring|September 14, 2020
Body Surface Area Dosing of High-Dose Methotrexate Should Be Reconsidered, Particularly in Overweight, Adult PatientsFanny Gallais, Lucie Oberic, Stanislas Faguer, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 19, 2018
Safety of oral hydration after cisplatin infusion in an outpatient lung cancer unitFlorent Puisset, Laurence Bigay-Game, Marie Noëlle Paludetto, et al.
Pharmaceuticals (Basel, Switzerland)|March 6, 2021
Limited Sampling Strategy for Determination of Ibrutinib Plasma Exposure: Joint Analyses with Metabolite DataFélicien Le Louedec, Fanny Gallais, Fabienne Thomas, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|October 30, 2020
Assessment of efficacy of postinfusion tubing flushing in reducing risk of cytotoxic contaminationPauline Claraz, Isabelle Riff, Charlotte Vert, et al.
Cancer Chemotherapy and Pharmacology|May 11, 2004
Dexamethasone as a probe for docetaxel clearanceFlorent Puisset, Etienne Chatelut, Florence Dalenc, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|October 26, 2020
Brentuximab vedotin in real life, a seven year experience in patients with refractory/relapsed CD30+ T cell lymphomaLucie Oberic, Faustine Delzor, Caroline Protin, et al.
British Journal of Clinical Pharmacology|February 26, 2013
Population pharmacokinetics of rituximab with or without plasmapheresis in kidney patients with antibody-mediated diseaseFlorent Puisset, Mélanie White-Koning, Nassim Kamar, et al.
Bulletin Du Cancer|February 19, 2025
[French mapping of clinical pharmacy activities for older patients with cancer: A SFPO-SFPC survey]Chloé Herledan, Anne Toulemonde, Mathilde Sturmia, et al.
Pageof 3